| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.749 | 0.005 | 0.79 | Spasmolytic | 0.79 0.004 CID_154700027 | CID_154700027 | |
| 0.632 | 0.008 | 0.701 | Histamine release inhibitor | 0.701 0.005 CID_154700027 | CID_154700027 | |
| 0.644 | 0.02 | 0.644 | Analgesic | 0.573 0.032 CID_154700027 | ||
| 0.623 | 0.005 | 0.623 | Psychostimulant | 0.589 0.006 CID_154700027 | ||
| 0.558 | 0.004 | 0.558 | 5 Hydroxytryptamine 1F antagonist | 0.382 0.005 CID_154700027 | ||
| 0.497 | 0.004 | 0.56 | Mediator release inhibitor | 0.56 0.004 CID_154700027 | CID_154700027 | |
| 0.54 | 0.072 | 0.556 | Antiinflammatory | 0.556 0.066 CID_154700027 | CID_154700027 | |
| 0.497 | 0.029 | 0.507 | Calcium channel L-type activator | 0.507 0.025 CID_154700027 | CID_154700027 | |
| 0.473 | 0.01 | 0.473 | P-glycoprotein inhibitor | 0.429 0.013 CID_154700027 | ||
| 0.468 | 0.004 | 0.468 | Alpha 2b adrenoreceptor antagonist | 0.421 0.005 CID_154700027 | ||
| 0.466 | 0.004 | 0.466 | 5 Hydroxytryptamine uptake inhibitor | 0.317 0.005 CID_154700027 | ||
| 0.457 | 0.004 | 0.457 | Alpha 2c adrenoreceptor antagonist | 0.421 0.004 CID_154700027 | ||
| 0.451 | 0.002 | 0.451 | Sphingomyelinase inhibitor | 0.365 0.003 CID_154700027 | ||
| 0.479 | 0.031 | 0.511 | 5 Hydroxytryptamine release stimulant | 0.511 0.025 CID_154700027 | CID_154700027 | |
| 0.414 | 0.025 | 0.414 | HERG channel blocker | 0.201 0.09 CID_154700027 | ||
| 0.44 | 0.055 | 0.567 | Transcription factor NF kappa B inhibitor | 0.567 0.035 CID_154700027 | CID_154700027 | |
| 0.396 | 0.022 | 0.396 | Anticonvulsant | 0.223 0.069 CID_154700027 | ||
| 0.391 | 0.028 | 0.391 | Potassium channel (Voltage-sensitive) blocker | 0.199 0.096 CID_154700027 | ||
| 0.365 | 0.005 | 0.365 | Alpha 2a adrenoreceptor antagonist | 0.355 0.005 CID_154700027 | ||
| 0.36 | 0.004 | 0.36 | Adrenaline uptake inhibitor | 0.258 0.005 CID_154700027 | ||
| 0.36 | 0.005 | 0.36 | Alpha 2 adrenoreceptor antagonist | 0.32 0.007 CID_154700027 | ||
| 0.377 | 0.027 | 0.377 | Potassium channel blocker | 0.182 0.105 CID_154700027 | ||
| 0.354 | 0.005 | 0.354 | Histamine H1 receptor antagonist | 0.215 0.013 CID_154700027 | ||
| 0.335 | 0.007 | 0.335 | Nav1.3 sodium channel blocker | 0.232 0.017 CID_154700027 | ||
| 0.327 | 0.009 | 0.327 | Antihistaminic | 0.155 0.031 CID_154700027 | ||
| 0.362 | 0.05 | 0.362 | Vasodilator, coronary | 0.36 0.05 CID_154700027 | ||
| 0.315 | 0.004 | 0.315 | 5 Hydroxytryptamine 3E antagonist | 0.253 0.014 CID_154700027 | ||
| 0.317 | 0.009 | 0.317 | Histamine antagonist | 0.138 0.033 CID_154700027 | ||
| 0.298 | 0.015 | 0.298 | Antipruritic | 0.295 0.015 CID_154700027 | ||
| 0.286 | 0.017 | 0.286 | 5 Hydroxytryptamine 2 antagonist | 0.188 0.034 CID_154700027 | ||
| 0.281 | 0.017 | 0.281 | Alpha adrenoreceptor antagonist | 0.237 0.022 CID_154700027 | ||
| 0.285 | 0.022 | 0.37 | MAO inhibitor | 0.37 0.014 CID_154700027 | CID_154700027 | |
| 0.262 | 0.004 | 0.262 | 5 Hydroxytryptamine 5A antagonist | 0.203 0.005 CID_154700027 | ||
| 0.261 | 0.004 | 0.261 | 5 Hydroxytryptamine 5 antagonist | 0.195 0.005 CID_154700027 | ||
| 0.26 | 0.014 | 0.26 | 5 Hydroxytryptamine 2A antagonist | 0.153 0.028 CID_154700027 | ||
| 0.369 | 0.129 | 0.436 | Apoptosis agonist | 0.436 0.097 CID_154700027 | CID_154700027 | |
| 0.252 | 0.013 | 0.253 | ATPase inhibitor | 0.253 0.013 CID_154700027 | CID_154700027 | |
| 0.315 | 0.079 | 0.337 | Antithrombotic | 0.337 0.069 CID_154700027 | CID_154700027 | |
| 0.291 | 0.056 | 0.291 | Platelet antagonist | 0.264 0.066 CID_154700027 | ||
| 0.247 | 0.025 | 0.247 | 5 Hydroxytryptamine antagonist | 0.136 0.056 CID_154700027 | ||
| 0.239 | 0.024 | 0.239 | Nav1.2 sodium channel blocker | 0.182 0.041 CID_154700027 | ||
| 0.228 | 0.014 | 0.228 | 5 Hydroxytryptamine 1 antagonist | 0.143 0.025 CID_154700027 | ||
| 0.258 | 0.047 | 0.268 | Anesthetic general | 0.268 0.043 CID_154700027 | CID_154700027 | |
| 0.232 | 0.03 | 0.232 | Acetylcholine M1 receptor antagonist | 0.223 0.033 CID_154700027 | ||
| 0.223 | 0.026 | 0.223 | Anesthetic local | 0.174 0.04 CID_154700027 | ||
| 0.206 | 0.012 | 0.206 | 5 Hydroxytryptamine 7 antagonist | 0.117 0.022 CID_154700027 | ||
| 0.216 | 0.021 | 0.216 | Antiadrenergic | 0.184 0.027 CID_154700027 | ||
| 0.198 | 0.007 | 0.198 | 5 Hydroxytryptamine 1D antagonist | 0.123 0.016 CID_154700027 | ||
| 0.346 | 0.155 | 0.346 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.261 | 0.075 | 0.261 | Cardiotonic | 0.214 0.107 CID_154700027 | ||
| 0.188 | 0.009 | 0.188 | 5 Hydroxytryptamine 1B antagonist | 0.107 0.02 CID_154700027 | ||
| 0.204 | 0.025 | 0.247 | Topoisomerase I inhibitor | 0.247 0.017 CID_154700027 | CID_154700027 | |
| 0.238 | 0.06 | 0.252 | Peptidyltransferase inhibitor | 0.252 0.05 CID_154700027 | CID_154700027 | |
| 0.182 | 0.006 | 0.182 | Histamine H2 receptor antagonist | 0.126 0.018 CID_154700027 | ||
| 0.199 | 0.024 | 0.199 | Adrenaline antagonist | 0.17 0.03 CID_154700027 | ||
| 0.2 | 0.027 | 0.2 | 5 Hydroxytryptamine 2B antagonist | 0.14 0.045 CID_154700027 | ||
| 0.189 | 0.016 | 0.189 | Alpha 1b adrenoreceptor antagonist | 0.157 0.021 CID_154700027 | ||
| 0.198 | 0.026 | 0.242 | Adenylate cyclase inhibitor | 0.242 0.02 CID_154700027 | CID_154700027 | |
| 0.184 | 0.023 | 0.184 | Alpha 1 adrenoreceptor antagonist | 0.141 0.031 CID_154700027 | ||
| 0.177 | 0.021 | 0.177 | 5 Hydroxytryptamine 2C antagonist | 0.113 0.039 CID_154700027 | ||
| 0.27 | 0.114 | 0.27 | Vasodilator, peripheral | 0.27 0.114 CID_154700027 | ||
| 0.255 | 0.101 | 0.255 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.238 0.118 CID_154700027 | ||
| 0.177 | 0.025 | 0.177 | Nav1.4 sodium channel blocker | 0.173 0.026 CID_154700027 | ||
| 0.231 | 0.081 | 0.248 | Vasodilator | 0.248 0.07 CID_154700027 | CID_154700027 | |
| 0.321 | 0.171 | 0.397 | Caspase 9 stimulant | 0.397 0.113 CID_154700027 | CID_154700027 | |
| 0.163 | 0.018 | 0.163 | 5 Hydroxytryptamine 1A antagonist | 0.112 0.028 CID_154700027 | ||
| 0.277 | 0.132 | 0.281 | GABA C receptor rho-3 antagonist | 0.281 0.129 CID_154700027 | CID_154700027 | |
| 0.18 | 0.038 | 0.18 | Cholinergic antagonist | 0.165 0.045 CID_154700027 | ||
| 0.162 | 0.021 | 0.162 | Nav1.5 sodium channel blocker | 0.119 0.055 CID_154700027 | ||
| 0.153 | 0.014 | 0.153 | Toll-Like receptor 3 antagonist | 0.125 0.026 CID_154700027 | ||
| 0.161 | 0.022 | 0.161 | Alpha 1a adrenoreceptor antagonist | 0.116 0.031 CID_154700027 | ||
| 0.151 | 0.014 | 0.151 | Alpha 1d adrenoreceptor antagonist | 0.111 0.021 CID_154700027 | ||
| 0.23 | 0.097 | 0.23 | 5 Hydroxytryptamine 1E antagonist | 0.227 0.1 CID_154700027 | ||
| 0.164 | 0.037 | 0.246 | MAO A inhibitor | 0.246 0.021 CID_154700027 | CID_154700027 | |
| 0.131 | 0.008 | 0.177 | Beta 3 adrenoreceptor antagonist | 0.177 0.004 CID_154700027 | CID_154700027 | |
| 0.159 | 0.039 | 0.159 | Acetylcholine muscarinic antagonist | 0.15 0.044 CID_154700027 | ||
| 0.133 | 0.014 | 0.133 | Acetylcholine M4 receptor antagonist | 0.085 0.041 CID_154700027 | ||
| 0.163 | 0.044 | 0.179 | Adenylate cyclase stimulant | 0.179 0.026 CID_154700027 | CID_154700027 | |
| 0.134 | 0.017 | 0.25 | Dopamine D1 antagonist | 0.25 0.008 CID_154700027 | CID_154700027 | |
| 0.214 | 0.104 | 0.238 | DNA damaging | 0.238 0.088 CID_154700027 | CID_154700027 | |
| 0.122 | 0.014 | 0.122 | Dopamine uptake inhibitor | 0.088 0.022 CID_154700027 | ||
| 0.153 | 0.048 | 0.153 | Acetylcholine antagonist | 0.139 0.056 CID_154700027 | ||
| 0.157 | 0.051 | 0.157 | Acetylcholinesterase inhibitor | 0.157 0.051 CID_154700027 | ||
| 0.127 | 0.024 | 0.127 | Glutamate (mGluR7) agonist | |||
| 0.25 | 0.147 | 0.25 | Calcium channel activator | 0.218 0.188 CID_154700027 | ||
| 0.115 | 0.014 | 0.115 | Acetylcholine M5 receptor antagonist | 0.089 0.021 CID_154700027 | ||
| 0.159 | 0.062 | 0.16 | GABA C receptor rho-2 antagonist | 0.16 0.061 CID_154700027 | CID_154700027 | |
| 0.1 | 0.006 | 0.1 | 5 Hydroxytryptamine 4 antagonist | 0.068 0.018 CID_154700027 | ||
| 0.122 | 0.031 | 0.122 | Dopamine antagonist | 0.119 0.032 CID_154700027 | ||
| 0.134 | 0.044 | 0.181 | MAO B inhibitor | 0.181 0.028 CID_154700027 | CID_154700027 | |
| 0.095 | 0.005 | 0.095 | 5 Hydroxytryptamine 3B antagonist | 0.043 0.019 CID_154700027 | ||
| 0.104 | 0.015 | 0.131 | Beta adrenoreceptor antagonist | 0.131 0.008 CID_154700027 | CID_154700027 | |
| 0.136 | 0.051 | 0.153 | Papain-like protease (SARS coronavirus) inhibitor | 0.153 0.031 CID_154700027 | CID_154700027 | |
| 0.146 | 0.062 | 0.146 | Calcium channel blocker | |||
| 0.094 | 0.012 | 0.115 | Beta 1 adrenoreceptor antagonist | 0.115 0.008 CID_154700027 | CID_154700027 | |
| 0.212 | 0.131 | 0.212 | Gastrin inhibitor | |||
| 0.141 | 0.061 | 0.141 | Sodium channel (voltage-gated) blocker | |||
| 0.109 | 0.032 | 0.109 | CYP2A6 inhibitor | |||
| 0.124 | 0.047 | 0.218 | Estrogen antagonist | 0.218 0.011 CID_154700027 | CID_154700027 | |
| 0.085 | 0.01 | 0.085 | Potassium channel (Inward rectifier) blocker | 0.049 0.035 CID_154700027 | ||
| 0.099 | 0.025 | 0.099 | Dopamine D3 antagonist | 0.08 0.032 CID_154700027 | ||
| 0.087 | 0.016 | 0.087 | Thromboxane antagonist | 0.081 0.02 CID_154700027 | ||
| 0.088 | 0.019 | 0.088 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.083 | 0.013 | 0.083 | Thromboxane A2 antagonist | 0.077 0.017 CID_154700027 | ||
| 0.172 | 0.105 | 0.172 | Platelet aggregation inhibitor | 0.156 0.121 CID_154700027 | ||
| 0.08 | 0.013 | 0.08 | 5 Hydroxytryptamine 1B agonist | 0.063 0.023 CID_154700027 | ||
| 0.138 | 0.071 | 0.138 | Toll-Like receptor 9 antagonist | 0.111 0.097 CID_154700027 | ||
| 0.111 | 0.045 | 0.193 | Estrogen receptor beta antagonist | 0.193 0.01 CID_154700027 | CID_154700027 | |
| 0.087 | 0.021 | 0.104 | Androgen agonist | 0.104 0.013 CID_154700027 | CID_154700027 | |
| 0.135 | 0.07 | 0.135 | Sodium channel blocker | |||
| 0.145 | 0.081 | 0.145 | Cholinergic | 0.132 0.094 CID_154700027 | ||
| 0.266 | 0.206 | 0.282 | 5 Hydroxytryptamine release inhibitor | 0.282 0.186 CID_154700027 | CID_154700027 | |
| 0.083 | 0.025 | 0.091 | Acetylcholine M3 receptor antagonist | 0.091 0.021 CID_154700027 | CID_154700027 | |
| 0.062 | 0.004 | 0.086 | Estrogen-related receptor beta antagonist | 0.086 0.003 CID_154700027 | CID_154700027 | |
| 0.073 | 0.015 | 0.098 | Beta 2 adrenoreceptor antagonist | 0.098 0.008 CID_154700027 | CID_154700027 | |
| 0.072 | 0.016 | 0.072 | Thromboxane synthase inhibitor | 0.066 0.02 CID_154700027 | ||
| 0.198 | 0.143 | 0.318 | Lipoxygenase inhibitor | 0.318 0.062 CID_154700027 | CID_154700027 | |
| 0.073 | 0.019 | 0.073 | Dopamine transporter inhibitor | 0.05 0.032 CID_154700027 | ||
| 0.085 | 0.034 | 0.085 | Calcium channel L-type blocker | |||
| 0.08 | 0.029 | 0.115 | Beta tubulin antagonist | 0.115 0.019 CID_154700027 | CID_154700027 | |
| 0.097 | 0.047 | 0.1 | Ornithine decarboxylase inhibitor | 0.1 0.044 CID_154700027 | CID_154700027 | |
| 0.202 | 0.154 | 0.212 | Insulysin inhibitor | 0.212 0.14 CID_154700027 | CID_154700027 | |
| 0.056 | 0.009 | 0.056 | Melatonin 2 agonist | 0.052 0.01 CID_154700027 | ||
| 0.068 | 0.02 | 0.068 | 5 Hydroxytryptamine 2 agonist | 0.045 0.043 CID_154700027 | ||
| 0.052 | 0.007 | 0.052 | Melatonin receptor 1A agonist | 0.038 0.016 CID_154700027 | ||
| 0.083 | 0.038 | 0.083 | Dopamine D2 antagonist | 0.079 0.04 CID_154700027 | ||
| 0.101 | 0.058 | 0.101 | Nitric-oxide synthase inhibitor | |||
| 0.121 | 0.079 | 0.16 | Tubulin antagonist | 0.16 0.054 CID_154700027 | CID_154700027 | |
| 0.153 | 0.112 | 0.17 | Non-steroidal antiinflammatory agent | 0.17 0.095 CID_154700027 | CID_154700027 | |
| 0.074 | 0.034 | 0.074 | Acetylcholine M2 receptor antagonist | 0.061 0.044 CID_154700027 | ||
| 0.191 | 0.152 | 0.223 | Tyrosine 3 hydroxylase inhibitor | 0.223 0.099 CID_154700027 | CID_154700027 | |
| 0.135 | 0.096 | 0.144 | Heat shock protein 70 antagonist | 0.144 0.063 CID_154700027 | CID_154700027 | |
| 0.098 | 0.066 | 0.098 | GABA C receptor rho-1 antagonist | 0.09 0.078 CID_154700027 | ||
| 0.037 | 0.007 | 0.037 | Prostaglandin H2 antagonist | 0.032 0.011 CID_154700027 | ||
| 0.101 | 0.072 | 0.112 | DNA intercalator | 0.112 0.063 CID_154700027 | CID_154700027 | |
| 0.094 | 0.068 | 0.156 | 5-Lipoxygenase inhibitor | 0.156 0.036 CID_154700027 | CID_154700027 | |
| 0.04 | 0.015 | 0.04 | Melatonin 1 agonist | 0.035 0.02 CID_154700027 | ||
| 0.04 | 0.015 | 0.04 | Melatonin agonist | 0.034 0.021 CID_154700027 | ||
| 0.145 | 0.121 | 0.154 | Succinate dehydrogenase inhibitor | 0.154 0.105 CID_154700027 | CID_154700027 | |
| 0.042 | 0.018 | 0.042 | Delayed rectifier potassium channel blocker | 0.038 0.024 CID_154700027 | ||
| 0.096 | 0.073 | 0.118 | Carbonic anhydrase XV inhibitor | 0.118 0.048 CID_154700027 | CID_154700027 | |
| 0.059 | 0.036 | 0.059 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.109 | 0.087 | 0.109 | RET inhibitor | |||
| 0.166 | 0.146 | 0.294 | Antioxidant | 0.294 0.064 CID_154700027 | CID_154700027 | |
| 0.157 | 0.138 | 0.23 | Antiamyloidogenic | 0.23 0.081 CID_154700027 | CID_154700027 | |
| 0.098 | 0.08 | 0.098 | GABA C receptor antagonist | 0.093 0.09 CID_154700027 | ||
| 0.115 | 0.097 | 0.117 | Histone deacetylase SIRT1 inhibitor | 0.117 0.095 CID_154700027 | CID_154700027 | |
| 0.1 | 0.084 | 0.1 | Calcium channel (voltage-sensitive) blocker | |||
| 0.081 | 0.065 | 0.088 | Myeloperoxidase inhibitor | 0.088 0.051 CID_154700027 | CID_154700027 | |
| 0.044 | 0.029 | 0.044 | Histamine H1 receptor agonist | |||
| 0.151 | 0.137 | 0.204 | Neurotrophic factor enhancer | 0.204 0.072 CID_154700027 | CID_154700027 | |
| 0.08 | 0.068 | 0.08 | mTOR complex 2 inhibitor | |||
| 0.027 | 0.015 | 0.034 | Dopamine autoreceptor agonist | 0.034 0.011 CID_154700027 | CID_154700027 | |
| 0.045 | 0.034 | 0.045 | Adenylate cyclase 1 inhibitor | |||
| 0.046 | 0.036 | 0.046 | Mineralocorticoid receptor antagonist | |||
| 0.058 | 0.048 | 0.058 | 5 Hydroxytryptamine 2A agonist | |||
| 0.046 | 0.037 | 0.046 | Sigma receptor antagonist | |||
| 0.016 | 0.007 | 0.016 | Melatonin receptor 1A antagonist | |||
| 0.038 | 0.03 | 0.038 | Histone deacetylase 9 inhibitor | |||
| 0.093 | 0.086 | 0.093 | Factor V inhibitor | |||
| 0.113 | 0.107 | 0.114 | Neurotrophic factor | 0.114 0.106 CID_154700027 | CID_154700027 | |
| 0.108 | 0.103 | 0.108 | DNA repair enzyme inhibitor | |||
| 0.071 | 0.066 | 0.119 | Estrogen receptor alpha antagonist | 0.119 0.019 CID_154700027 | CID_154700027 | |
| 0.125 | 0.123 | 0.169 | Melanin inhibitor | 0.169 0.06 CID_154700027 | CID_154700027 | |
| 0.017 | 0.015 | 0.017 | Alpha 2c adrenoreceptor agonist | |||
| 0.024 | 0.036 | 0.035 | Estrogen-related receptor alpha antagonist | 0.035 0.02 CID_154700027 | CID_154700027 | |
| 0.028 | 0.041 | 0.036 | Opioid delta receptor agonist | 0.036 0.023 CID_154700027 | CID_154700027 | |
| 0.131 | 0.144 | 0.158 | Antimitotic | 0.158 0.114 CID_154700027 | CID_154700027 | |
| 0.075 | 0.089 | 0.11 | Alcohol dehydrogenase inhibitor | 0.11 0.043 CID_154700027 | CID_154700027 | |
| 0.075 | 0.092 | 0.082 | ATPase (Vacuolar H+) inhibitor | 0.082 0.074 CID_154700027 | CID_154700027 | |
| 0.067 | 0.088 | 0.092 | Antineoplastic alkaloid | 0.092 0.053 CID_154700027 | CID_154700027 | |
| 0.099 | 0.123 | 0.133 | Protein kinase stimulant | 0.133 0.081 CID_154700027 | CID_154700027 | |
| 0.054 | 0.084 | 0.063 | Beta 2 adrenoreceptor agonist | 0.063 0.036 CID_154700027 | CID_154700027 | |
| 0.09 | 0.12 | 0.132 | Bone formation stimulant | 0.132 0.075 CID_154700027 | CID_154700027 | |
| 0.111 | 0.144 | 0.226 | Amyloid beta aggregation inhibitor | 0.226 0.066 CID_154700027 | CID_154700027 | |
| 0.026 | 0.06 | 0.048 | Dopamine D5 agonist | 0.048 0.019 CID_154700027 | CID_154700027 | |
| 0.041 | 0.077 | 0.061 | Dopamine agonist | 0.061 0.051 CID_154700027 | CID_154700027 | |
| 0.025 | 0.065 | 0.038 | Opioid kappa receptor agonist | 0.038 0.037 CID_154700027 | CID_154700027 | |
| 0.07 | 0.111 | 0.088 | Estrogen-related receptor beta agonist | 0.088 0.044 CID_154700027 | CID_154700027 | |
| 0.051 | 0.098 | 0.078 | Analgesic, opioid | 0.078 0.05 CID_154700027 | CID_154700027 | |
| 0.055 | 0.106 | 0.09 | Adrenaline agonist | 0.09 0.045 CID_154700027 | CID_154700027 | |
| 0.136 | 0.191 | 0.162 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.162 0.122 CID_154700027 | CID_154700027 | |
| 0.169 | 0.231 | 0.209 | Immunosuppressant | 0.209 0.187 CID_154700027 | CID_154700027 | |
| 0.14 | 0.205 | 0.175 | Superoxide dismutase inhibitor | 0.175 0.149 CID_154700027 | CID_154700027 | |
| 0.034 | 0.101 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.042 CID_154700027 | CID_154700027 | |
| 0.065 | 0.136 | 0.098 | Carbonic anhydrase III inhibitor | 0.098 0.065 CID_154700027 | CID_154700027 | |
| 0.107 | 0.179 | 0.149 | Hepatoprotectant | 0.149 0.11 CID_154700027 | CID_154700027 | |
| 0.076 | 0.155 | 0.103 | Aldehyde dehydrogenase inhibitor | 0.103 0.093 CID_154700027 | CID_154700027 | |
| 0.061 | 0.141 | 0.125 | Topoisomerase II inhibitor | 0.125 0.063 CID_154700027 | CID_154700027 | |
| 0.014 | 0.097 | 0.081 | Estrogen agonist | 0.081 0.023 CID_154700027 | CID_154700027 | |
| 0.101 | 0.192 | 0.125 | Interferon gamma antagonist | 0.125 0.122 CID_154700027 | CID_154700027 | |
| 0.045 | 0.142 | 0.114 | Monophenol monooxygenase inhibitor | 0.114 0.066 CID_154700027 | CID_154700027 | |
| 0.073 | 0.171 | 0.114 | Toll-Like receptor 2 antagonist | 0.114 0.084 CID_154700027 | CID_154700027 | |
| 0.154 | 0.263 | 0.227 | Caspase 3 stimulant | 0.227 0.134 CID_154700027 | CID_154700027 | |
| 0.037 | 0.146 | 0.075 | Topoisomerase II alpha inhibitor | 0.075 0.057 CID_154700027 | CID_154700027 | |
| 0.054 | 0.163 | 0.133 | M18 aspartyl aminopeptidase inhibitor | 0.133 0.061 CID_154700027 | CID_154700027 | |
| 0.005 | 0.124 | 0.031 | Estrogen receptor beta agonist | 0.031 0.023 CID_154700027 | CID_154700027 | |
| 0.053 | 0.172 | 0.102 | Chelator | 0.102 0.074 CID_154700027 | CID_154700027 | |
| 0.088 | 0.211 | 0.137 | Nitric oxide antagonist | 0.137 0.109 CID_154700027 | CID_154700027 | |
| 0.048 | 0.177 | 0.096 | Creatine kinase inhibitor | 0.096 0.064 CID_154700027 | CID_154700027 | |
| 0.09 | 0.23 | 0.181 | Aldehyde oxidase inhibitor | 0.181 0.116 CID_154700027 | CID_154700027 | |
| 0.037 | 0.182 | 0.071 | Macrophage migration inhibitory factor inhibitor | 0.071 0.064 CID_154700027 | CID_154700027 | |
| 0.122 | 0.272 | 0.19 | Hypoxia-inducible factor 1 alpha inhibitor | 0.19 0.165 CID_154700027 | CID_154700027 | |
| 0.134 | 0.293 | 0.237 | 15-Lipoxygenase inhibitor | 0.237 0.175 CID_154700027 | CID_154700027 | |
| 0.088 | 0.255 | 0.225 | Free radical scavenger | 0.225 0.08 CID_154700027 | CID_154700027 | |
| 0.045 | 0.254 | 0.127 | Lipid peroxidase inhibitor | 0.127 0.087 CID_154700027 | CID_154700027 | |
| 0.083 | 0.45 | 0.215 | Sodium/bile acid cotransporter inhibitor | 0.215 0.168 CID_154700027 | CID_154700027 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |